These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
263 related items for PubMed ID: 16254965
1. Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7. Tan GH, Yusoff K, Seow HF, Tan WS. J Med Virol; 2005 Dec; 77(4):475-80. PubMed ID: 16254965 [Abstract] [Full Text] [Related]
2. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system. Chen Y, Xiong X, Liu X, Li J, Wen Y, Chen Y, Dai Q, Cao Z, Yu W. Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486 [Abstract] [Full Text] [Related]
3. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies. Vietheer PT, Boo I, Drummer HE, Netter HJ. Antivir Ther; 2007 Feb; 12(4):477-87. PubMed ID: 17668556 [Abstract] [Full Text] [Related]
4. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen. Shiau AL, Murray K. J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078 [Abstract] [Full Text] [Related]
5. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus. Bremer CM, Sominskaya I, Skrastina D, Pumpens P, El Wahed AA, Beutling U, Frank R, Fritz HJ, Hunsmann G, Gerlich WH, Glebe D. J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866 [Abstract] [Full Text] [Related]
6. A mimotope of pre-S2 region of surface antigen of viral hepatitis B screened by phage display. Zhang WY, Wan Y, Li DG, Tang Y, Zhou W. Cell Res; 2001 Sep; 11(3):203-8. PubMed ID: 11642405 [Abstract] [Full Text] [Related]
7. Behavior of a short preS1 epitope on the surface of hepatitis B core particles. Borisova G, Borschukova O, Skrastina D, Dislers A, Ose V, Pumpens P, Grens E. Biol Chem; 1999 Mar; 380(3):315-24. PubMed ID: 10223334 [Abstract] [Full Text] [Related]
8. The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. Tian Y, Xu Y, Zhang Z, Meng Z, Qin L, Lu M, Yang D. J Clin Microbiol; 2007 Sep; 45(9):2971-8. PubMed ID: 17609325 [Abstract] [Full Text] [Related]
9. Display of hepatitis B virus PreS1 peptide on bacteriophage T7 and its potential in gene delivery into HepG2 cells. Tang KH, Yusoff K, Tan WS. J Virol Methods; 2009 Aug; 159(2):194-9. PubMed ID: 19490973 [Abstract] [Full Text] [Related]
10. A phage-displayed cyclic peptide that interacts tightly with the immunodominant region of hepatitis B surface antigen. Tan WS, Tan GH, Yusoff K, Seow HF. J Clin Virol; 2005 Sep; 34(1):35-41. PubMed ID: 16087122 [Abstract] [Full Text] [Related]
11. Reduced antigenicity of naturally occurring hepatitis B surface antigen variants with substitutions at the amino acid residue 126. Qiu S, Zhang J, Tian Y, Yang Y, Huang H, Yang D, Lu M, Xu Y. Intervirology; 2008 Sep; 51(6):400-6. PubMed ID: 19258718 [Abstract] [Full Text] [Related]
12. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen. Desombere I, Willems A, Gijbels Y, Leroux-Roels G. J Virol; 2006 Apr; 80(7):3506-14. PubMed ID: 16537618 [Abstract] [Full Text] [Related]
13. Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines. Michel M, Lone YC, Centlivre M, Roux P, Wain-Hobson S, Sala M. Vaccine; 2007 Feb 26; 25(10):1901-11. PubMed ID: 17005303 [Abstract] [Full Text] [Related]
14. Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers. Roque-Afonso AM, Férey MP, Ly TD, Graube A, Costa-Faria L, Samuel D, Dussaix E. Antivir Ther; 2007 Feb 26; 12(8):1255-63. PubMed ID: 18240865 [Abstract] [Full Text] [Related]
15. A unique amino acid substitution, T126I, in human genotype C of hepatitis B virus S gene and its possible influence on antigenic structural change. Ren F, Tsubota A, Hirokawa T, Kumada H, Yang Z, Tanaka H. Gene; 2006 Nov 15; 383():43-51. PubMed ID: 16963200 [Abstract] [Full Text] [Related]
16. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Zhang JM, Xu Y, Wang XY, Yin YK, Wu XH, Weng XH, Lu M. Clin Infect Dis; 2007 May 01; 44(9):1161-9. PubMed ID: 17407033 [Abstract] [Full Text] [Related]
17. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine. Li X, Yang X, Li L, Liu H, Liu J. Vaccine; 2006 Apr 12; 24(16):3321-31. PubMed ID: 16472546 [Abstract] [Full Text] [Related]
18. [Construction and characterization of hepatitis B surface antigen "a" epitope virus-like particles]. Chen SY, Guo MZ, Qiu F, Fei YL, Yi Y, Guo Y, Jia ZY, Yu T, Bi SL. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb 12; 24(1):30-2. PubMed ID: 20848844 [Abstract] [Full Text] [Related]
19. Definition of the primary structure of hepatitis B virus (HBV) pre-S hepatocyte binding domain using random peptide libraries. D'Mello F, Partidos CD, Steward MW, Howard CR. Virology; 1997 Oct 27; 237(2):319-26. PubMed ID: 9356343 [Abstract] [Full Text] [Related]
20. An hepatitis B virus surface antigen specific single chain of variable fragment derived from a natural immune antigen binding fragment phage display library is specifically internalized by HepG2.2.15 cells. Wen WH, Qin WJ, Gao H, Zhao J, Jia LT, Liao QH, Meng YL, Jin BQ, Yao LB, Chen SY, Yang AG. J Viral Hepat; 2007 Jul 27; 14(7):512-9. PubMed ID: 17576393 [Abstract] [Full Text] [Related] Page: [Next] [New Search]